Research
Our research philosophy
Pelago is dedicated to delivering safe and effective care for our members. In order to do so we turn to science, conducting research and peer-reviewed studies. Substance use disorders can be treated in a variety of ways, including social support, therapy, medication or a combination of treatments. But what is the most effective? Through rigorous research, we validate and refine our treatment approaches, leveraging outcomes of scientific inquiry to guide custom solutions for each individual who participates in our programs.
We’ve found some interesting results so far and we encourage you to take a look at the data yourself.
52%
biochemically-verified quit rate at 28 days
44%
biochemically verified quit rate at 26 weeks post-quit date
71%
more likely to remain abstinent from tobacco at 12 months
Economic Impact of an Employer-Sponsored Integrated Digital Intervention Targeting Substance Use Disorders
Change in Substance Use Treatment Costs
$6,758
Average medical cost savings per participants over 12 months
4.5:1
Return on investment in 12 months (including Pelago program fee)
33%
Lower medical spend driven by fewer inpatient, outpatient, and ER claims
Feasibility and acceptability of a novel digital therapeutic combining behavioral and pharmacological treatment for opioid use disorder
Number of Abstinent Days (past 30)
67%
abstinent over 90 days
95%
average medication adherence
overall decrease in depression & anxiety
overall increase in well-being
Implementing Suicide Risk Screening in a Virtual Addiction Clinic
252
Screened patients
7.5%
Screen-positive rate
100%
of clinicians were comfortable asking patients about suicidal thoughts and behaviors
Feasibility and Preliminary Outcomes of a Mobile Intervention Combining Cognitive Behavioral Therapy, Virtual Coaching, and Nicotine Replacement Therapy for Nicotine Vaping Cessation
87%
of participants quit vaping
time vaping decreased from 75.8 minutes to 26.5 minutes
days vaping decreased from 24.7 to 3.9
Feasibility, Acceptability, and Preliminary Outcomes of an Integrated Telemedicine Intervention Combining Naltrexone and Cognitive Behavioral Therapy for Alcohol Use Disorder
Changes in mean percentage of days abstinent
68%
of participants reduced their alcohol use
drinks per day decreased from 6.7 to 2.7
96%
participation and satisfaction
Say hello to brighter days together
Get started quickly. Reduce healthcare spend. Change lives forever.